Healthworx Accelerator
Overview
Healthworx Accelerator is a healthcare-focused accelerator program and the innovation and investment arm of CareFirst, which provides funding and mentorship to early-stage startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Doro Mind Inc. | Feb 2026 | Seed | Co-investor |
| WellSet | Apr 2021 | Accelerator | Co-investor |
| LiverRight | Jan 2025 | Accelerator | Co-investor |
| SocialRx Inc | Nov 2025 | Accelerator | Co-investor |
| Basys.ai | Sep 2024 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Healthworx Accelerator based?
Healthworx Accelerator is headquartered in Baltimore, Maryland, United States.
When was Healthworx Accelerator founded?
Healthworx Accelerator was founded in 2024.
How many portfolio companies does Healthworx Accelerator have?
Healthworx Accelerator has 11 portfolio companies in Caplight's dataset.
What are some companies in Healthworx Accelerator's portfolio?
Portfolio companies visible on Caplight include Doro Mind Inc., WellSet, LiverRight, SocialRx Inc, Basys.ai.
What was Healthworx Accelerator's most recent investment shown here?
Healthworx Accelerator's most recent investment in this portfolio sample was in Doro Mind Inc. in 2026.
What sectors does Healthworx Accelerator focus on?
Healthworx Accelerator focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Consumer & Commerce, Enterprise Software.
What company stages does Healthworx Accelerator focus on?
Healthworx Accelerator typically invests at the Early stage.